The IV heparin recommended by Peter F. Cohn, MD, as bridging therapy when warfarin has to be stopped in a pa-tient with an artificial heart valve (Item 99-12) requires a long hospital stay. Why not ...
February 17, 2010 (Paris, France) — A new-point-of care test that can be used in the cath lab to monitor anticoagulation levels of enoxaparin (Lovenox, Sanofi-Aventis) has been shown to give reliable ...
A simple-to-use strategy that prevents blood clots in patients who have suffered a heart attack markedly reduces the risk of repeat heart attack or death when compared to an older, more widely used ...
Effects of admission (adm) source, time, and provider on inpatient (inpt) oncology (onc) outcomes at the Cleveland Clinic Foundation (CCF).
The U.S. Food and Drug Administration today approved the first generic version of Lovenox (enoxaparin sodium injection), an anti-coagulant drug used to prevent deep vein thrombosis (DVT), a ...
Aspirin alone doesn’t seem to be enough to prevent symptomatic venous thromboembolism (VTE) in the months following total hip or knee replacement for osteoarthritis, results of the CRISTAL trial ...
Lovenox (enoxaparin) is a prescription drug used to prevent or treat certain types of blood clots. Lovenox’s cost may depend on factors such as your dosage, whether you have health insurance, and how ...
LONDON, June 5 (Reuters) - Doctors in Europe can continue to use Sanofi-Aventis SA's heparin medicine Lovenox, despite low levels of contamination found in some batches of the product, the European ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results